These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3363645)

  • 21. "Cyclosporine-A nephrotoxicity in renal allograft recipients".
    Nix K; Plawecki HM
    J Nephrol Nurs; 1985; 2(5):220-2. PubMed ID: 3903104
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal outcome after ciclosporin-induced nephrotoxicity.
    Tostivint I; du Montcel ST; Jaudon MC; Mallet A; Le Hoang P; Bodaghi B; Deray G; Bagnis CI
    Nephrol Dial Transplant; 2007 Mar; 22(3):880-5. PubMed ID: 17127700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine dose adjustment in patients with normal serum creatinine and trough levels: a challenge for successful long-term treatment.
    Cantarovich F; Cantarovich D; Touraine JL; Tizado J; Castro LZ; Correa C; Herman AP; Traeger J
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):402-6. PubMed ID: 3284084
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence against chronic progressive cyclosporine nephrotoxicity.
    Ben-Maimon CS; Burke JF; Besarab A; Jarrell BE; Francos GC; Moyer SS
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1260-2. PubMed ID: 1989206
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects on renal function of combined treatment with trimethoprim and cyclosporine A in kidney transplant patients.
    Berg KJ; Nordby G; Rootwelt K; Djøseland O; Fauchald P; Mehl A; Narverud J; Talseth T
    Transplant Proc; 1988 Jun; 20(3):413-5. PubMed ID: 3289171
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of lithium clearance measurements to assess renal tubular function in experimental and clinical cyclosporine nephrotoxicity.
    Whiting PH; Propper DJ; Simpson JG; McKay J; Jones MC; Catto GR
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):675-80. PubMed ID: 3388506
    [No Abstract]   [Full Text] [Related]  

  • 27. Serum creatinine levels two years later: follow-up of a placebo-controlled trial of cyclosporine in rheumatoid patients.
    Boers M; van Rijthoven AW; Goei Thè HS; Dijkmans BA; Cats A
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):371-5. PubMed ID: 3289212
    [No Abstract]   [Full Text] [Related]  

  • 28. Are serum creatinine levels adequate to identify the onset of chronic cyclosporine A nephrotoxicity?
    Mobb GE; Veitch PS; Bell PR
    Transplant Proc; 1990 Aug; 22(4):1708-10. PubMed ID: 2389439
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of cyclosporine on the early postoperative function of allografted kidneys with warm ischemic damage.
    Ohshima S; Fujita T; Asano H; Ono Y
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2081-4. PubMed ID: 3547911
    [No Abstract]   [Full Text] [Related]  

  • 30. Impaired fractional excretion of lithium: an early marker of cyclosporine-induced changes in renal hemodynamics.
    Vincent HH; Wenting GJ; Versluis DJ; Weimar W; Schalekamp MA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):681-5. PubMed ID: 3291303
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of cyclosporine in cadaveric renal transplantation in China.
    Xie T; Xu QJ
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):99-101. PubMed ID: 3291336
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal structure and function effects after low dose cyclosporine in psoriasis patients: a preliminary report.
    Messana JM; Johnson KJ; Mihatsch MJ
    Clin Nephrol; 1995 Mar; 43(3):150-3. PubMed ID: 7774069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The case against conversion to azathioprine in cyclosporine-treated renal recipients.
    Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of chronic cyclosporine nephrotoxicity in renal transplantation by picotamide.
    Quarto Di Palo F; Elli A; Rivolta R; Parenti M; Palazzi P; Zanussi C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):969-71. PubMed ID: 1989347
    [No Abstract]   [Full Text] [Related]  

  • 35. Nephrotoxicity and hypertension in patients with autoimmune disease treated with cyclosporine.
    Dieterle A; Abeywickrama K; von Graffenried B
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):349-55. PubMed ID: 3381297
    [No Abstract]   [Full Text] [Related]  

  • 36. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 37. Cyclosporine levels are not helpful.
    Henry ML; Bowers VD; Fanning WJ; Sommer BG; Ferguson RM
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):419-21. PubMed ID: 3284086
    [No Abstract]   [Full Text] [Related]  

  • 38. Cyclosporin A nephrotoxicity.
    Dieperink H
    Dan Med Bull; 1989 Jun; 36(3):235-48. PubMed ID: 2666036
    [No Abstract]   [Full Text] [Related]  

  • 39. Nephrotoxicity of trimethoprim and cotrimoxazole in renal allograft recipients treated with cyclosporine.
    Thompson JF; Chalmers DH; Hunnisett AG; Wood RF; Morris PJ
    Transplantation; 1983 Aug; 36(2):204-6. PubMed ID: 6349046
    [No Abstract]   [Full Text] [Related]  

  • 40. Long-term results of cyclosporine in cadaveric renal transplantation from a single center.
    Jain AB; Buckels JA; Adu D; Michael J; Mackintosh P; McMaster P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):82-5. PubMed ID: 3291320
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.